Patents by Inventor Oliver Dosenbach

Oliver Dosenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279709
    Abstract: Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes of formula (I) and their use in electronic devices, especially electroluminescent devices. When used as charge transport material, charge blocker material and/or host material in electroluminescent devices, the specifically substituted aza-dibenzofurans and aza-dibenzothiophenes may provide improved efficiency, stability, manufacturability, or spectral characteristics of electroluminescent devices and reduced driving voltage of electroluminescent devices. In formula (I) Y is S or O; one of X1-X8 is N; another X1-X8 is C-L(R9)—[X9X10X11]Ring; and the remaining X1-X8 are CR1-CR8 wherein R1-R8 are independently H, alkyl, alkenyl, aryl, etc.
    Type: Grant
    Filed: September 4, 2017
    Date of Patent: March 22, 2022
    Assignee: IDEMITSU KOSAN CO., LTD.
    Inventors: Annemarie Wolleb, Heinz Wolleb, Hideaki Nagashima, Oliver Dosenbach, Takushi Shiomi
  • Publication number: 20190248804
    Abstract: Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes of formula (I) and their use in electronic devices, especially electroluminescent devices. When used as charge transport material, charge blocker material and/or host material in electroluminescent devices, the specifically substituted aza-dibenzofurans and aza-dibenzothiophenes may provide improved efficiency, stability, manufacturability, or spectral characteristics of electroluminescent devices and reduced driving voltage of electroluminescent devices. In formula (I) Y is S or O; one of X1-X8 is N; another X1-X8 is C-L(R9)-[X9X10X11]Ring; and the remaining X1-X8 are CR1—CR8 wherein R1-R8 are independently H, alkyl, alkenyl, aryl, etc.
    Type: Application
    Filed: September 4, 2017
    Publication date: August 15, 2019
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Annemarie WOLLEB, Heinz WOLLEB, Hideaki NAGASHIMA, Oliver DOSENBACH, Takushi SHIOMI
  • Publication number: 20190131547
    Abstract: The present invention relates to compounds of formula (I), which are characterized in that they substituted by benzimidazo[1,2-a]benzimidazo-5-yl and/or benzimidazo[1,2-a]benzimidazo-2,5-ylene groups and in that at least one of the substituents B1, B2, B3, B4, B5, B6, B7 and B8 represents N; a process for their production and their use in electronic devices, especially electroluminescent devices. When used as host material for phosphorescent emitters in electroluminescent devices, the compounds of formula I may provide improved efficiency, stability, manufacturability, or spectral characteristics of electroluminescent devices.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 2, 2019
    Inventors: Annemarie Wolleb, Thomas Schaefer, Heinz Wolleb, Ute Heinemeyer, Nicolle Langer, Christian Lennartz, Gerhard Wagenblast, Soichi Watanabe, Flavio Luiz Benedito, Heinz Hottinger, Oliver Dosenbach
  • Patent number: 10249827
    Abstract: The present invention relates to compounds of formula (I), which are characterized in that they substituted by benzimidazo[1,2-a]benzimidazo-5-yl and/or benzimidazo[1,2-a]benzimidazo-2,5-ylene groups and in that at least one of the substituents B1, B2, B3, B4, B5, B6, B7 and B8 represents N; a process for their production and their use in electronic devices, especially electroluminescent devices. When used as host material for phosphorescent emitters in electroluminescent devices, the compounds of formula I may provide improved efficiency, stability, manufacturability, or spectral characteristics of electroluminescent devices.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: April 2, 2019
    Assignee: UDC Ireland Limited
    Inventors: Annemarie Wolleb, Thomas Schaefer, Heinz Wolleb, Ute Heinemeyer, Nicolle Langer, Christian Lennartz, Gerhard Wagenblast, Soichi Watanabe, Flavio Luiz Benedito, Heinz Hottinger, Oliver Dosenbach
  • Publication number: 20150243907
    Abstract: The present invention relates to compounds of formula (I), which are characterized in that they substituted by benzimidazo[1,2-a]benzimidazo-5-yl and/or benzimidazo[1,2-a]benzimidazo-2,5-ylene groups and in that at least one of the substituents B1, B2, B3, B4, B5, B6, B7 and B8 represents N; a process for their production and their use in electronic devices, especially electroluminescent devices. When used as host material for phosphorescent emitters in electroluminescent devices, the compounds of formula I may provide improved efficiency, stability, manufacturability, or spectral characteristics of electroluminescent devices.
    Type: Application
    Filed: September 18, 2013
    Publication date: August 27, 2015
    Applicant: BASF SE
    Inventors: Annemarie Wolleb, Thomas Schaefer, Heinz Wolleb, Ute Heinemeyer, Nicolle Langer, Christian Lennartz, Gerhard Wagenblast, Soichi Watanabe, Flavio Luiz Benedito, Heinz Hottinger, Oliver Dosenbach
  • Patent number: 8822702
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: September 2, 2014
    Assignee: BASF SE
    Inventors: Ulrich Berens, Oliver Dosenbach, Daniel Sprenger
  • Patent number: 8710093
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: April 29, 2014
    Assignee: BASF SE Ludwigshafen
    Inventors: Ulrich Berens, Oliver Dosenbach, Daniel Sprenger
  • Publication number: 20120220782
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Application
    Filed: April 30, 2012
    Publication date: August 30, 2012
    Inventors: Ulrich BERENS, Oliver DOSENBACH, Daniel SPRENGER
  • Publication number: 20110207941
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Application
    Filed: May 2, 2011
    Publication date: August 25, 2011
    Inventors: ULRICH BERENS, OLIVER DOSENBACH, DANIEL SPRENGER
  • Patent number: 7968730
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: June 28, 2011
    Assignee: BASF SE
    Inventors: Ulrich Berens, Oliver Dosenbach, Daniel Sprenger
  • Patent number: 7786156
    Abstract: The invention relates to a process for the manufacture of an 1,2,4-triazol-1-yl compound of the formula [A], or a salt thereof, wherein each of R3 and R4 is hydrogen or lower alkyl, said process comprising reacting a hydrazine compound of the formula [B] wherein R is hydrogen or acyl, R2 is hydrogen or a protecting group, are hydrogen or lower alkyl, and R6 is hydrogen or COOR7, or a salt thereof, with a 1,2,4-triazolyl forming reagent. In addition, novel intermediates for the synthesis of the anti-migraine agent Rizatriptan and methods for their synthesis are presented.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: August 31, 2010
    Assignee: ratiopharm GmbH
    Inventors: Pierre Martin, Ulrich Berens, Andreas Boudier, Oliver Dosenbach
  • Publication number: 20100087660
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, or especially of amides of the formula II, wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Application
    Filed: December 7, 2009
    Publication date: April 8, 2010
    Inventors: ULRICH BERENS, OLIVER DOSENBACH, DANIEL SPRENGER
  • Patent number: 7645886
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula (I), or especially of amides of the formula (II), wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: January 12, 2010
    Assignee: Ciba Specialty Corporation
    Inventors: Ulrich Berens, Oliver Dosenbach, Daniel Sprenger
  • Publication number: 20070123711
    Abstract: The invention relates to a process for the manufacture of an 1,2,4-triazol-1-yl compound of the formula [A], or a salt thereof, wherein each of R3 and R4 is hydrogen or lower alkyl, said process comprising reacting a hydrazine compound of the formula [B] wherein R is hydrogen or acyl, R2 is hydrogen or a protecting group, are hydrogen or lower alkyl, and R6 is hydrogen or COOR7, or a salt thereof, with a 1,2,4-triazolyl forming reagent. In addition, novel intermediates for the synthesis of the anti-migraine agent Rizatriptan and methods for their synthesis are presented.
    Type: Application
    Filed: January 27, 2005
    Publication date: May 31, 2007
    Inventors: Pierre Martin, Ulrich Berens, Andreas Boudier, Oliver Dosenbach
  • Publication number: 20060058367
    Abstract: The invention relates in a first embodiment to a method for the manufacture of esters of the formula (I), or especially of amides of the formula (II), wherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.
    Type: Application
    Filed: December 12, 2003
    Publication date: March 16, 2006
    Inventors: Ulrich Berens, Oliver Dosenbach, Daniel Sprenger
  • Patent number: 6809208
    Abstract: The invention describes novel compounds of the formula (I) wherein the general symbols are as defined in claim (1) and R1 is an aromatic radical with electron withdrawing substituents, as stabilizers for protecting organic materials, in particular polymers and lubricants, against oxidative, thermal or light-induced degradation and as scavengers for oxidized developer in color photographic material.
    Type: Grant
    Filed: August 12, 2002
    Date of Patent: October 26, 2004
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Michael Tinkl, Oliver Dosenbach, Peter Nesvadba, Martin Wolff, Bruno Rotzinger, Dietmar Mäder
  • Publication number: 20030212170
    Abstract: The invention describes novel compounds of the formula (I) wherein the general symbols are as defined in claim (1) and R1 is an aromatic radical with electron withdrawing substituents, as stabilizers for protecting organic materials, in particular polymers and lubricants, against oxidative, thermal or light-induced degradation and as scavengers for oxidized developer in color photographic material.
    Type: Application
    Filed: August 12, 2002
    Publication date: November 13, 2003
    Inventors: Michael Tinkl, Oliver Dosenbach, Peter Nesvadba, Martin Wolff, Bruno Rotzinger, Dietmar Mader